<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>33(4)</volume><submitter>Falini B</submitter><funding>Associazione Italiana per la Ricerca sul Cancro</funding><funding>European Research Council</funding><journal>Leukemia</journal><pagination>1043-1047</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6484707</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>IDH1-R132 changes vary according to NPM1 and other mutations status in AML.</pubmed_title><pmcid>PMC6484707</pmcid><funding_grant_id>AIRC IG 2016 n.18568</funding_grant_id><funding_grant_id>740230</funding_grant_id><funding_grant_id>ERC Adv Grant 2016 n. 740230</funding_grant_id><pubmed_authors>Falini B</pubmed_authors><pubmed_authors>Haferlach T</pubmed_authors><pubmed_authors>Spinelli O</pubmed_authors><pubmed_authors>Bigerna B</pubmed_authors><pubmed_authors>Stein H</pubmed_authors><pubmed_authors>Martelli MP</pubmed_authors><pubmed_authors>Rambaldi A</pubmed_authors><pubmed_authors>Ascani S</pubmed_authors><pubmed_authors>Meggendorfer M</pubmed_authors></additional><is_claimable>false</is_claimable><name>IDH1-R132 changes vary according to NPM1 and other mutations status in AML.</name><description/><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Apr</publication><modification>2026-04-29T02:15:36.349Z</modification><creation>2025-04-07T08:22:48.449Z</creation></dates><accession>S-EPMC6484707</accession><cross_references><pubmed>30622284</pubmed><doi>10.1038/s41375-018-0299-2</doi></cross_references></HashMap>